Transcript Access to HIV/AIDS Medicines The 3x5 strategy WHO/EDM Technical Briefing Seminar 15-19 March 2004

Access to HIV/AIDS Medicines
The 3x5 strategy
WHO/EDM Technical Briefing
Seminar
15-19 March 2004
Three by Five

The goal is universal access to anti-retroviral
therapy as a human right

The target is three million people on treatment
by the end of 2005

The treatment gap was declared a global
health emergency Sept 22nd at UNGA
Pillar 1: WHO and global level
activities




1. Visible WHO leadership and commitment to urgent
action to reach the goal of universal access to ART
Momentum created
2. Locate the rights-based 3x5 initiative within the
broader development context
3. Support all national efforts whilst focusing WHO
resources on high-burden and strategic countries to
achieve maximal impact of 3x5 initiative
Country owned process
4. Align and mobilize partner support to achieve 3x5
target at global level
Member States
UNAIDS Co-sponsors
Other partners
Pillar 2: Country Support Efforts

5. Secure the key elements required at the national
level to deliver the 3x5 target as part of a
comprehensive response to HIV/AIDS

6. Strengthen and support the renewal of health
systems and national operational capacity for scaling up
ART programs
National Medicines Policy
(Selection, procurement, regulation,
supply chain management, rational use)

7. Strengthen and build human capacity for scaling up
ART

8. Expand capacity of communities to be fully involved
in ART program planning and delivery
Pillar 3: simplified, standardised tools

9. Simplify and standardize procedures to identify
individuals in need of therapy and facilitate entry to ART
programs
Rapid test based approach

10. Simplify and standardize ARV therapy to facilitate
adherence and enable rapid scale-up to be implemented
4 First-line treatments
FDCs and Blisters
11. Simplify and standardize tools for tracking ART
program performance including drug resistance
surveillance
Standardized M&E Guidelines

Pillar 4: Effective medicines and
diagnostics supply

12. Support country access to , and efficient
distribution of high quality, low cost medicines
and diagnostics
Pillar 5: Success stories and learning
by doing

13. Build on success

14. Continuously learn by doing - with
ongoing evaluation and analysis of program
performance and a focused operational
research agenda.
AMDS objectives

Ensure that the supply of quality commodities is
never an obstacle to expanding treatment, care
and support

Use improved commodity supply to catalyze
rapid expansion of treatment, to promote
equity, to support prevention
AMDS general principles




Use partners to best capacity
Don’t develop new structures/systems
All partners involved in planning and further
expansion
Support all available channels (government,
NGOs, insurances)
What the AMDS will do
Assist/support a country-driven process……

Create information hub



Serve as “one-stop-shop” for specific support


Bring together strategic information from existing sources
(ensure ease of access)
Develop new tools as needed (self or contracted)
Initiate and act as gateway for information and Technical
Assistance by partners inside and outside WHO
Support operational staff

(Recruit), train and support dedicated procurement and
supply chain management staff
What the AMDS does not plan to
do………

No procurement itself but



No repeat /duplicate effort



Support countries to buy/manage supplies
Direct to appropriate services
 ARVs: PQ Procurement agencies
 Diagnostics: WHO bulk procurement scheme
Use ongoing work, available expertise and information
No new structures MOH, NGO.
No funding to purchase commodities
Examples of EDM action and guidance
on Access to HIV-Related Medicines*


13th WHO Model List of Essential Medicines, including
(since 12th edition including ARVs)
2nd WHO Model Formulary, including section on ARVs

Pre-qualification of HIV medicines and manufacturers
(R&D and generic)

Annual Reports on “Sources and Prices of Selected
Drugs and Diagnostics for People Living With
HIV/AIDS; jointly with UNICEF, UNAIDS, MSF

Operational Principles for Good Pharmaceutical
Procurement – IPC group

Globalization, TRIPS and Access to Pharmaceuticals.
WHO Policy Perspectives on Medicines
* Available on EDM web site (http://www.who.int/medicines/)
For further
information……….
Peter Graaff
[email protected]